EP Patent

EP0507224B1 — Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions

Assigned to Alcon Vision LLC · Expires 1996-10-30 · 30y expired

What this patent protects

Ophthalmic compositions comprising combinations of gelling polysaccharides and finely-divided drug carrier substrates which become relatively more viscous on contact with the eye are disclosed. Ophthalmic compositions further comprising a pharmaceutically active drug are also dis…

USPTO Abstract

Ophthalmic compositions comprising combinations of gelling polysaccharides and finely-divided drug carrier substrates which become relatively more viscous on contact with the eye are disclosed. Ophthalmic compositions further comprising a pharmaceutically active drug are also disclosed, as are methods of use. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
EP0507224B1
Jurisdiction
EP
Classification
Expires
1996-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Alcon Vision LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.